Published in Phys Med Biol on January 30, 2009
Quantitative tumor oxymetric images from 4D electron paramagnetic resonance imaging (EPRI): methodology and comparison with blood oxygen level-dependent (BOLD) MRI. Magn Reson Med (2003) 3.02
Evaluation of sparse-view reconstruction from flat-panel-detector cone-beam CT. Phys Med Biol (2010) 2.95
Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol (2007) 2.44
Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys (2002) 2.03
Spin echo spectroscopic electron paramagnetic resonance imaging. Magn Reson Med (2006) 2.02
Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.89
Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys (2005) 1.85
Electron paramagnetic resonance oxygen image hypoxic fraction plus radiation dose strongly correlates with tumor cure in FSa fibrosarcomas. Int J Radiat Oncol Biol Phys (2008) 1.84
Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice. J Nucl Med (2003) 1.76
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer (2011) 1.70
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin Cancer Res (2008) 1.68
Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.62
MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy. J Nucl Med (2010) 1.61
Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys (2002) 1.61
Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys (2003) 1.59
Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys (2008) 1.57
Region of interest reconstruction from truncated data in circular cone-beam CT. IEEE Trans Med Imaging (2006) 1.55
Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys (2004) 1.52
A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients. Int J Radiat Oncol Biol Phys (2006) 1.50
Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys (2003) 1.46
MicroRNA expression characterizes oligometastasis(es). PLoS One (2011) 1.45
Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol (2011) 1.42
Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2005) 1.38
Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity. Int J Radiat Oncol Biol Phys (2010) 1.30
Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys (2010) 1.25
Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.22
A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol (2009) 1.16
Exact reconstruction of volumetric images in reverse helical cone-beam CT. Med Phys (2008) 1.13
Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs. PLoS One (2012) 1.11
Immobilization Using Dental Material Casts Facilitates Accurate Serial and Multimodality Small Animal Imaging. Concepts Magn Reson Part B Magn Reson Eng (2008) 1.09
Predictors of competing mortality in early breast cancer. Cancer (2010) 1.08
Receiver operating characteristic analysis: a general tool for DNA array data filtration and performance estimation. Genomics (2003) 1.08
MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients. BMC Med Genomics (2010) 1.08
Calculation and prediction of the effect of respiratory motion on whole breast radiation therapy dose distributions. Med Dosim (2008) 1.03
Feasibility and acute toxicity of hypofractionated radiation in large-breasted patients. Int J Radiat Oncol Biol Phys (2011) 1.03
A novel functional CT contrast agent for molecular imaging of cancer. Phys Med Biol (2010) 1.03
EPR oxygen images predict tumor control by a 50% tumor control radiation dose. Cancer Res (2013) 1.03
Region-of-interest image reconstruction in circular cone-beam microCT. Med Phys (2007) 1.02
An analysis of radiation necrosis of the central nervous system treated with bevacizumab. J Neurooncol (2014) 1.02
Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis. BMC Cancer (2003) 0.99
Where it's at really matters: in situ in vivo vascular endothelial growth factor spatially correlates with electron paramagnetic resonance pO2 images in tumors of living mice. Mol Imaging Biol (2011) 0.98
A Gaussian mixture model for definition of lung tumor volumes in positron emission tomography. Med Phys (2007) 0.98
Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists. Am J Clin Oncol (2017) 0.97
The development and testing of a digital PET phantom for the evaluation of tumor volume segmentation techniques. Med Phys (2008) 0.96
Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer (2008) 0.96
Total marrow irradiation with RapidArc volumetric arc therapy. Int J Radiat Oncol Biol Phys (2011) 0.96
Lung texture in serial thoracic CT scans: assessment of change introduced by image registration. Med Phys (2012) 0.96
Characterization of response to radiation mediated gene therapy by means of multimodality imaging. Magn Reson Med (2009) 0.94
A survey of intensity-modulated radiation therapy use in the United States. Cancer (2003) 0.94
Inhibition of serine palmitoyltransferase delays the onset of radiation-induced pulmonary fibrosis through the negative regulation of sphingosine kinase-1 expression. J Lipid Res (2012) 0.93
Radiation oncology fourth-year medical student clerkships: a targeted needs assessment. Int J Radiat Oncol Biol Phys (2012) 0.93
Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat Rev (2003) 0.92
The H+/K+-ATPase (proton) pump is expressed in human laryngeal submucosal glands. Laryngoscope (2003) 0.92
A hybrid approach to reducing computed tomography metal artifacts in intracavitary brachytherapy. Brachytherapy (2005) 0.92
Proton pump (H+/K+-ATPase) expression in human laryngeal seromucinous glands. Otolaryngol Head Neck Surg (2005) 0.91
Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. Int J Radiat Oncol Biol Phys (2012) 0.91
Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer. J Thorac Oncol (2012) 0.91
Predictors of tumor control in patients treated with linac-based stereotactic radiosurgery for metastatic disease to the brain. Am J Clin Oncol (2005) 0.91
Human lung mucous glands manifest evidence of the H+/K+-ATPase proton pump. Ann Otol Rhinol Laryngol (2007) 0.91
AuNP-DG: deoxyglucose-labeled gold nanoparticles as X-ray computed tomography contrast agents for cancer imaging. Mol Imaging Biol (2010) 0.90
Region-of-interest image reconstruction with intensity weighting in circular cone-beam CT for image-guided radiation therapy. Med Phys (2009) 0.89
Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance? Cancer (2005) 0.88
Linac-based intensity modulated total marrow irradiation (IM-TMI). Technol Cancer Res Treat (2006) 0.88
Can intensity-modulated radiation therapy replace brachytherapy in the management of cervical cancer? Counterpoint. Brachytherapy (2002) 0.87
Reduction of image artifacts in mice by bladder flushing with a novel double-lumen urethral catheter. Mol Imaging (2006) 0.87
High-resolution MRI of excised human prostate specimens acquired with 9.4T in detection and identification of cancers: validation of a technique. J Magn Reson Imaging (2011) 0.86
Feasibility study for linac-based intensity modulated total marrow irradiation. Med Phys (2008) 0.86
Late rectal toxicity after prostate brachytherapy: influence of supplemental external beam radiation on dose-volume histogram analysis. Brachytherapy (2009) 0.86
Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1. J Vasc Surg (2005) 0.86
Chiral bis-acetal porphyrazines as near-infrared optical agents for detection and treatment of cancer. Photochem Photobiol (2010) 0.85
Nitrosative stress induces DNA strand breaks but not caspase mediated apoptosis in a lung cancer cell line. J Carcinog (2004) 0.85
Hypofractionated radiotherapy does not increase acute toxicity in large-breasted women: results from a prospectively collected series. Am J Clin Oncol (2014) 0.85
Intensity-modulated radiation therapy in gynecologic malignancies. Med Dosim (2002) 0.84
Nitric oxide: perspectives and emerging studies of a well known cytotoxin. Int J Mol Sci (2010) 0.84
Developing a structure-function relationship for anionic porphyrazines exhibiting selective anti-tumor activity. J Photochem Photobiol B (2006) 0.83
Reduction of computed tomography metal artifacts due to the Fletcher-Suit applicator in gynecology patients receiving intracavitary brachytherapy. Brachytherapy (2003) 0.83
Charge dependence of cellular uptake and selective antitumor activity of porphyrazines. J Med Chem (2005) 0.83
Survey of resident education in intensity-modulated radiation therapy. Technol Cancer Res Treat (2005) 0.83
Western blot confirmation of the H+/K+-ATPase proton pump in the human larynx and submandibular gland. Otolaryngol Head Neck Surg (2011) 0.83
Verification of dose distribution for volumetric modulated arc therapy total marrow irradiation in a humanlike phantom. Med Phys (2012) 0.82
Synthesis and characterization of new porphyrazine-Gd(III) conjugates as multimodal MR contrast agents. Bioconjug Chem (2010) 0.81